Globus Medical, Inc.
GMEDHealthcareNASDAQMedical Devices · Last scanned Jul 18, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Globus Medical, Inc. focuses on Medical Devices services and products. Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. At a $10.45B market cap, Globus Medical, Inc. ranks as a large-cap company within healthcare. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives.
Market Cap
$10.45B
Beta
0.95
P/E (TTM)
18.92
P/E (Fwd)
14.95
EPS (TTM)
$4.07
EPS (Fwd)
$5.15
ROE
13.3%
ROA
8.2%
Cash
$629.9M
Total Debt
$115.9M
Free CF
$341.1M
52W Change
36.7%
Annual Financials
Cash vs Debt
With $629.9M in cash and $115.9M in debt, GMED maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $341.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 13.3%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $1.02B (2022) to $2.94B (2025), reflecting a 187% increase over the period.
With cash comfortably exceeding debt, GMED has financial flexibility that may help navigate uncertain periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Globus Medical, Inc.'s trajectory.